Clinical Trial Update: Dupilumab_Metastatic NSCLC [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update indicates a Phase 1/Phase 2 study of dupilumab in metastatic non-small cell lung cancer is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Dupilumab (dupilumab)

Snippet

Sponsor: Thomas Marron | Conditions: Metastatic Non-small Cell Lung Cancer | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING